EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

High‐Throughput Strategies for Streamlining Lipid Nanoparticle Development Pipeline

Lois Lam, Stephanie Watson, Yogambha Ramaswamy, Gurvinder Singh iD

Advanced Science · 2025-11 · 12 (42)

DOI: 10.1002/advs.202511551 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Science, online erschienen am 03.10.2025. Verfasst von Lois Lam und 3 weiteren Autor:innen. Beteiligte Einrichtung: The School of Biomedical Engineering, Faculty of IT and Engineering, Sydney Nano Institute, The University of Sydney, Camperdown, New South Wales, 20…. Hauptthemen laut MEDLINE: Nanoparticles, Lipids, High-Throughput Screening Assays. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 188 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipid nanoparticles (LNPs) have become clinically validated nanocarriers for nucleic acid delivery, enabling applications in mRNA vaccines and therapies for cancer, ocular, and infectious diseases. Identifying LNPs formulations with optimal physicochemical and pharmacokinetic properties using traditional low‐throughput methods is resource‐intensive and impractical for evaluating large libraries. Recent advances in automation, high‐throughput platforms for lipid synthesis, characterization, and screening tools are transforming the landscape of LNP formulation. These strategies enable rapid multi‐parametric generation and evaluation of hundreds to thousands of formulations across key properties such as size, charge, stability, biodistribution, cellular uptake, and intracellular trafficking. In parallel, advanced biomimetic models and in vivo multiplexed barcoding screening strategies provide deeper insights into tissue targeting and therapeutic delivery outcomes. This review provides an integrated framework that combines automation with high‐throughput combinatorial synthesis, characterization, and in vitro/in vivo screening tools. In this development pipeline, performance benchmarks applied at each step systematically exclude suboptimal candidates, ensuring that only clinically viable LNP candidates advance. Future directions, including automation, high‐throughput, and closed‐loop machine learning guided design strategies, are further discussed to advance the development of next‐generation LNP therapeutics and accelerate their translation from bench to bedside.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesLipidsHigh-Throughput Screening AssaysHumansAnimalsDrug Delivery SystemsLiposomes

Stichwörter der Autor:innen

barcoding strategiesclosed‐loop workflowhigh‐throughput screeninglipid nanoparticlesmachine learningtherapeutic delivery

Substanzen

LipidsLipid NanoparticlesLiposomes

Autor:innen und Institutionen

  • The School of Biomedical Engineering, Faculty of IT and Engineering, Sydney Nano Institute, The University of Sydney, Camperdown, New South Wales, 2008, Australia.
  • Sydney Medical School, Faculty of Medicine and Health, Sydney Nano Institute, The University of Sydney, Camperdown, New South Wales, 2008, Australia.

ORCID-Profile: Gurvinder Singh

Zitieren

APA

Lam, L., Watson, S., Ramaswamy, Y., & Singh, G. (2025). High‐Throughput Strategies for Streamlining Lipid Nanoparticle Development Pipeline. Advanced Science, 12(42). https://doi.org/10.1002/advs.202511551

Vancouver

Lam L, Watson S, Ramaswamy Y, Singh G. High‐Throughput Strategies for Streamlining Lipid Nanoparticle Development Pipeline. Advanced Science. 2025;12(42). doi:10.1002/advs.202511551

BibTeX
@article{Lam2025,
  author = {Lam, Lois and Watson, Stephanie and Ramaswamy, Yogambha and Singh, Gurvinder},
  title = {High‐Throughput Strategies for Streamlining Lipid Nanoparticle Development Pipeline},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {42},
  doi = {10.1002/advs.202511551}
}
Kostenlos starten →